Pharmafile Logo

Why health psychology should inform pharma strategy

In the March 2016 edition of PME, Ella Nuttall (Health Psychology Specialist at Lucid Group) discusses why pharma should look to health psychology and adopt a behaviour-change strategy to inform the design of medical education programmes. As pressure mounts on the pharmaceutical industry to demonstrate tangible and positive impact on patients’ lives, understanding barriers to specific clinician behaviours is key to achieving measurable change in clinical practice, and advancing patient outcomes. 

Health psychology and behaviour change principles are at the core of Lucid’s strategy. Ella explains how Lucid’s five-step behaviour change model, Advance Outcomes®, is an integral part in the development of their award-winning medical education programmes. By staying up to date with the latest academic thinking in behaviour-change techniques, Ella ensures that Lucid constantly evolves their unique approach to stay ahead of the game. 

You can learn more about Ella’s expertise and the role of health psychology in medical education by reading the full article at 
http://goo.gl/Rwp3aN
- PMLiVE

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid Strategy Consulting: Empowering Next-Generation Solutions for Life Sciences

Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid...

My Lucid journey from PMW to Head of Medical

Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced...

Listen, learn and lift off

In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the...

Launch excellence

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines...

Meet The Lucid Group Talent Team

Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 1)

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on...

My Journey into MedComms #LucidLife

I began as a medical writer after almost a decade working in medical publishing as a production editor. Whilst working in publishing, I was exposed to lots of different writing...